YSPSAH logo

Y.S.P. Southeast Asia Holding Berhad Stock Price

KLSE:YSPSAH Community·RM 286.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

YSPSAH Share Price Performance

RM 2.02
-0.02 (-0.98%)
RM 2.02
-0.02 (-0.98%)
Price RM 2.02

YSPSAH Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

2 Risks
2 Rewards

Y.S.P. Southeast Asia Holding Berhad Key Details

RM 369.5m

Revenue

RM 209.4m

Cost of Revenue

RM 160.1m

Gross Profit

RM 133.1m

Other Expenses

RM 27.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.19
43.34%
7.31%
6.8%
View Full Analysis

About YSPSAH

Founded
1987
Employees
1361
CEO
Fang-Hsin Lee
WebsiteView website
www.yspsah.com

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also manufactures aquatic, cosmetic, and biotechnology and health products, as well as traditional herbal medicines, food and health supplements, and over-the-counter products; and offers management services. Y.S.P. Southeast Asia Holding Berhad was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.

Recent YSPSAH News & Updates

Recent updates

No updates